Pietro
Zambonardi

Mid-Level Associate
Ulteriora mirari, praesentia sequi Publio Cornelio Tacito

Pietro carries out his professional activity assisting Italian and foreign clients mainly in legal matters concerning the pharmaceutical, cosmetics, food supplement and medical devices sectors (Life Sciences).

He also assists clients in drafting opinions, negotiating and drafting contracts related to business activities.

Pietro has attended outsourcing programs for pharmaceutical companies focused on assisting day-to-day business.

Pietro joined LCA in February, 2024.
Previously, after a collaboration at the Avvocatura Distrettuale dello Stato in Milan, he worked with Studio Franzosi Dal Negro Setti from 2018 to 2024.

Commercial and corporate Life Sciences

You might also be interested in

12.11.2026
LCA Studio Legale strengthens its Corporate M&A Practice with the addition of ...

The firm consolidates its practice in extraordinary and cross-border transactions, with a focus on Private Equity

06.11.2026
LCA Law Firm Advises YK Robotics on Its Italy-Spain Cross-Border Reorganization an ...

The transaction involved a flip, the rollover of shares, and a change in the group’s jurisdiction.

05.11.2026
LCA Studio Legale advises Haslan Due on the acquisition of 100% of Lasertech

The transaction is part of a club deal led by CPI and Zero Capital to support Lasertech’s growth and internatio ...

21.10.2026
LCA advises CDP Venture Capital and Rialto on TrueLayer’s investment round

The UK open banking fintech raises $27 million from a consortium of new and existing investors.

09.10.2026
LCA advises the selling shareholders on the sale of Planta to SIS

The transaction strengthens the maize genetics platform of the BF group’s seed division

05.10.2026
LCA alongside Impresoft in the acquisition of Marketplace Generation and Addiction ...

The group controlled by Clessidra Private Equity strengthens its e-commerce and MarTech offering